Thus, CD147-CypA interactions can contribute to the proliferation of MF/SS tumor cells, and the disruption of CD147-CypA interactions could be seen as a new therapeutic strategy for the treatment of MF/SS [5]. The gene discussed is BSG; the disease is neoplasm.